Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors

Published:2019-10-03 Issue:10 Volume:28 Page:903-916
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Wang Dan¹²³,Yang Li¹²³,Yu Weina¹²³,Zhang Yi¹²³⁴

Affiliation:

1. Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China

2. Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China

3. Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, P.R. China

4. School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, P.R. China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1672655

Reference161 articles.

1. Targeting FGFR Signaling in Cancer

2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor

3. Fibroblast growth factor signalling: from development to cancer

4. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction

5. FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models;Phytomedicine;2024-07

2. 18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging;Frontiers in Oncology;2023-04-27

3. New developments in the biology of fibroblast growth factors;WIREs Mechanisms of Disease;2022-02-09

4. 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology;Journal of Oncology;2021-04-30

5. A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers;Frontiers in Oncology;2021-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3